Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Nagoya City University

Clinical trials sponsored by Nagoya City University, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Could a simple blood test tell some breast cancer patients It's safe to stop treatment? Results expected Dec 2026 (estimated)
  • New breast cancer trial aims to wipe out tumors before surgery Results expected Jun 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1
Sort by
  • Could a simple blood test tell some breast cancer patients It's safe to stop treatment?

    Knowledge-focused Ongoing

    This study is for people with HER2-positive metastatic breast cancer who have had a lasting response (complete or partial remission for over 2 years) on anti-HER2 therapy. Researchers will use a personalized blood test called Signatera to look for tiny amounts of cancer DNA. The …

    Sponsor: Nagoya City University • Aim: Knowledge-focused

    Last updated Jun 27, 2026 12:34 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space